Biocon
Second wave of Covid-19 has hit India 'like a tsunami': Kiran Mazumdar Shaw
Covid second wave has hit India 'like a tsunami' says Kiran Mazumdar Shaw
Amid weak showing by biosimilars and generics, downgrade pressure on Biocon
Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw
Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore

Nifty outlook & trading ideas by Gaurav Garg of CapitalVia Global Research
Top trading ideas by Ajit Mishra of Religare Broking: Buy Biocon, TVS Motor
Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil
Biocon, VIP Ind: Trading calls by Vaishali Parekh of Prabhudas Lilladher
Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Shaw